| Turchia | Austria | Spagna | |
| Terapia EV con resveratrolo | da $200 | da $600 | da $400 |
Bookimed non aggiunge costi extra ai prezzi di Terapia EV con resveratrolo. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Terapia EV con resveratrolo al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Terapia EV con resveratrolo e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Terapia EV con resveratrolo.
Dr. Piyaphon On-phoon specializes in anti-aging and regenerative medicine. He also provides chelation therapy and immune therapy with high-dose vitamin and nutrition infusions.
He treats erectile dysfunction and offers hormone replacement therapy. He provides preventive care for noncommunicable diseases such as hypertension, atherosclerosis, diabetes, and dyslipidemia. He also treats skin diseases and offers aesthetic procedures using laser, HIFU, Thermage, Botox, and filler injections.
Professor İlhan Mavioğlu is a cardiovascular surgeon and leads the Cardiovascular Surgery Outpatient Clinic. His focus areas include total arterial revascularization. He performs minimally invasive off-pump anaortic CABG (MACAB) and MIDCAB. He also performs awake carotid surgery. He manages peripheral vascular and endovascular procedures, including chimney TEVAR, EVAR, BEVAR, FEVAR, PEVAR, and CERAB, and handles related complications.
Education and accreditation: MD, Hacettepe University (1990). Cardiovascular surgery specialization, Dışkapı Yıldırım Beyazıt Training and Research Hospital (1996). Associate Professor, Mersin University (2003). Professor, Düzce University (2012). Certificates include endovascular training (2011) and Robotic Mitral Valve Repair (2014).
Publications include J Clin Med (2023), Innovations (2023), J Card Surg (2022), and Asian Cardiovasc Thorac Ann (2019). He also authored a 12-year infrarenal AAA mortality report (1999). He has been a member of national and European cardiovascular and vascular societies since 1992.